Varicella vaccine: genesis, efficacy, and attenuation.

Arvin, A M

Arvin, A M.

Affiliation

Arvin AM; Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA. aarvin@stanford.edu

Virology ; 284(2): 153-8, 2001 Jun 05.

Article in En | MEDLINE | ID: mdl-11384215

Subject(s)

Chickenpox Vaccine/immunology; Animals; Chickenpox Vaccine/genetics; Clinical Trials as Topic; Consensus Sequence; Genome, Viral; Herpesviridae Infections/prevention & control; Herpesvirus 3, Human/genetics; Herpesvirus 3, Human/immunology; Humans; Immunity, Cellular; Immunocompetence; Open Reading Frames; Sequence Analysis; Vaccination; Vaccines, Attenuated/genetics; Vaccines, Attenuated/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Chickenpox Vaccine Limits: Animals / Humans Language: En Journal: Virology Year: 2001 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links